Christopher R. Kelsey, MD, on DLBCL: Study Results on Consolidation Radiotherapy

2017 ASTRO Annual Meeting
Tweet this page

Christopher R. Kelsey, MD, of Duke University Medical Center, discusses reducing the radiation dose from 30 Gy to 20 Gy for patients with diffuse large B-cell lymphoma. Phase II findings show this approach may be effective in light of improved systemic treatment and better chemotherapy response assessment (Presentation 298).

Advertisement

Advertisement



Advertisement